E-cigarette Advertising Expenditures Tripled from 2011 to 2012, Study Finds


Electronic cigarette advertising expenditures tripled in the United States from $ 6.4 million in 2011 to $ 18.3 million in 2012, according to a study by RTI International.

The study, published in the April issue of American Journal of Preventive Medicine, is the first to comprehensively estimate e-cigarette ad expenditures across media channels in the United States. Researchers analyzed data from leading media companies that systematically track ad expenditures for consumer products in magazines, TV, newspapers, radio and the Internet.

“E-cigarette advertising expenditures are focusing heavily on national markets and TV ads, which will likely increase consumer awareness and use of e-cigarettes,” said Annice Kim, Ph.D., senior social scientist at RTI and co-author of the study.

The study found e-cigarette ad expenditures were highest in magazines and TV and lowest in newspapers and on the Internet. The study found e-cigarette magazine ad expenditures increased from $ 1.4 million in 2011 to $ 10.8 million in 2012, while TV ad expenditures grew from $ 3.2 million to $ 5 million.

Previous research by RTI indicated that adult smokers are receptive to e-cigarette TV ads and report intention to try e-cigarettes after viewing the ads. This research suggests that the increase in e-cigarette ad expenditures, particularly TV ads, will increase the likelihood of awareness and use of e-cigarettes.

The study also found national markets were increasingly targeted; comprising 54.9 percent of e-cigarette ad buys in 2011 and increasing to 87 percent in 2012.

RTI researchers identified more than 80 unique advertised brands; however, blu eCigs, a leading e-cigarette company, accounted for 76.7 percent of all e-cigarette advertising expenditures in 2012.

“Our results suggest that federal-level efforts are needed to track e-cigarette advertising, as the U.S. Federal Trade Commission does not currently require companies to report e-cigarette ad expenditures,” Kim said. “Tobacco companies are required to report their ad expenditures annually to the FTC, but there are no comparable reporting requirements for e-cigarette companies because e-cigarettes are not regulated by the U.S. Food and Drug Administration.”

Find More Buy E Cigs Press Releases

Smokers Achieve Best Quit Smoking Success Rate with Napa Valley Smoke-Free Life Program, According to Recent Research Study

St. Helena, CA (PRWEB) November 18, 2013

Smokers who participated in the St. Helena Center for a Smoke-Free Life residential stop-smoking program in Napa Valley have a 57% success rate after one year. Results of the Smoke-Free Life program research study, conducted by John E. Hodgkin, M.D., medical director of the program, and colleagues, were published in the September 2013 issue of the prestigious Mayo Clinic Proceedings journal (1), a publication of the Mayo Foundation for Medical Education and Research. The latest edition of Treating Tobacco Use and Dependence, Clinical Practice Guideline, published in 2008, reported success rates of 12.7% to 36.5% (see Table) for various strategies and medications (2). A recent study reported a 6 month success rate of 21.1% with the use of an e-cigarette (3). With no treatment (4), i.e. no medication or counseling, 95 to 97% of those trying to stop smoking relapse within one year!

Since 1969, the St. Helena Center for a Smoke-Free Life program has helped thousands of individuals. The program offers comprehensive individualized, intensive tobacco dependence treatment. The use of medications to suppress nicotine withdrawal symptoms is tailored to each individual. Participants in the program receive information on nutrition, stress management, sleep habits, spirituality and exercise with the intent to create a supportive environment when they complete the residential program and return home.

“The proper use of medications can greatly increase success rates,” stated Dr. John E. Hodgkin. “In addition, the tobacco-free environment our residential program provides, along with behavioral counseling, education and support, allows individuals to focus on their success. A residential smoking cessation program should be considered for those who have been unsuccessful in achieving tobacco abstinence despite serious attempts at quitting.”

Of the participants using the nicotine patch, 75.8% used more than the standard beginning nicotine patch dose of one 21mg. patch per day. The subgroup of those who used a combination of nicotine patch, bupropion, and short-acting nicotine medication achieved a non-smoking outcome at 12 months of 63.9%.

The study was the latest published by Dr. John E. Hodgkin. He has published over 200 journal articles and book chapters and is the lead editor of the foremost clinical textbook, Pulmonary Rehabilitation: Guidelines to Success (fourth edition, Mosby, 2009). Dr. Hodgkin received the Outstanding Clinician of the Year Award from the California Thoracic Society in 2007 and Physician of the Year Adventist Health Award in 2012.

For more information on the St. Helena Center for a Smoke-Free Life program, please call 800.358.9195 or visit http://www.sthelenacenterforhealth.org.

Table: Stop Smoking Success Rates*

St. Helena Smoke-Free Life Program (1) – 57.0%

One nicotine patch (> 14 weeks) + short-acting nicotine² – 36.5%

Varenidine (2) – 33.2%

One nicotine patch + Bupropion (2) – 28.9%

One nicotine product (usual dose) (2) – 19.0-26.7%

Bupropion (2) – 24.2%

Medication + Counseling (2) – 22.1%

E-cigarettes (3) – 21.1%

Counseling with no medications – 14.6%

Telephone quitline (2) – 12.7%

No help (2) – 3-5%

*All success rates listed are based on 7-day point prevalence (“no smoking, not one puff” in the previous 7 days) at six months, except for the St. Helena Smoke-Free Life Program which is at one year.


1. Hodgkin JE, Sachs DPL, Swan GE, Jack LM, Titus BL, Waldron SJS, Sachs BL, Brigham J.

Outcomes from a patient-centered residential treatment plan for tobacco dependence.

Mayo Clin Proc 2013; 88: 970-976.

2. Fiore MC, Jaén CR, Baker TB, et al.

Treating Tobacco Use and Dependence: 2008 Update.

Clinical Practice Guideline. Rockville, MD:

U.S. Department of Health and Human Services.

Public Health Service. May 2008.

3. Bullen C, Howe C, Laugesen M, et al.

Electronic cigarettes for smoking cessation: a randomized controlled trial.

Lancet 2013; published online Sept 7


4. Hughes JR, Keely J, Naud S.

Shape of the relapse curve and long-term abstinence among untreated smokers.

Addiction 2004; 99: 29-38.


St. Helena Hospital is part of Adventist Health, a faith-based, not-for-profit integrated health care delivery system serving communities in California, Hawaii, Oregon and Washington. Our workforce of 28,900 includes more than 21,200 employees; 4,500 medical staff physicians; and 3,200 volunteers. Founded on Seventh-day Adventist health values, Adventist Health provides compassionate care in 19 hospitals, more than 170 clinics (hospital-based, rural health and physician clinics), 14 home care agencies, six hospice agencies and four joint-venture retirement centers. We invite you to visit http://www.sthelenahospitals.org for more information.

Study Reveals That e-Cigarettes Present Increased Toxin Levels When Compared To Traditional Tobacco Smoke, Parker Waichman LLP Notes

Port Washington, New York (PRWEB) May 21, 2014

Parker Waichman LLP, a national law firm long dedicated to protecting the rights of victims injured by defective and dangerous products, notes that a new study, conducted by the Roswell Park Cancer Institute, reveals that e-cigarettes may expose users to increased levels, even higher than traditional tobacco, of very dangerous toxins, according to a Buffalo News report dated May 19, 2014.

The study appears in the peer-reviewed journal Nicotine and Tobacco Research’s May 2014 issue, and revealed that, while e-cigarettes that are operated at lower voltage levels generate trace levels of some toxins, when the voltage is increased the levels of those toxins were increased significantly.

Maciej Goniewicz, a researcher in the Department of Health Behavior said, “These results suggest that some types of electronic cigarettes might expose their users to the same or even higher levels of carcinogenic formaldehyde than tobacco smoke. Users of high-voltage e-cigarettes need to be warned about this increased risk of harmful effects,” according to the Buffalo News report.

Some e-cigarette devices are constructed with various elements, including the ability to change the device’s voltage level so that the user is able to choose to increase or decrease vapor production and nicotine delivery. The research reviewed the chemicals present in these e-cigarette vapors when different voltages are used. When operated at the increased voltages, the e-cigarette’s vapors included significant and dangerous levels of the carcinogenic chemical, formaldehyde; the potential carcinogen, acetaldehyde; and the nasal and lung tissue irritants, acrolein and acetone, according to the Buffalo News.

The research endeavored to understand which e-cigarette product elements, including nicotine solvent and battery output voltage impacted the carbonyl levels in the product’s vapors, and the effects of these on health. The research revealed that the most commonly used e-cigarette nicotine solvents are glycerin (VG) and propylene glycol (PG). When exposed to high temperatures, both VG and PG decompose, which creates lowered molecular carbonyl compounds, including carcinogens and potential carcinogens, according to Nicotine and Tobacco Research. The researchers concluded that the vapors released by e-cigarettes contain toxic and carcinogenic carbonyl compounds; that solvent and battery output voltage significantly affects carbonyl compounds levels in the vapors; and that high-voltage e-cigarettes may expose users to high carbonyl compound levels.

Goniewicz recommended more research to specifically study other e-cigarette product characteristics that may also impact the toxicity of e-cigarettes, such as heating elements, flavorings, and additives, the Buffalo News report indicated.

“The use of e-cigarettes is continuing to increase and, with advertising touting the devices as safe and as a safe alternative to traditional smoking, these devices are often used in public areas, exposing non-smokers to what may be dangerous vapors,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “More and more research is pointing to the hazards associated with those who use e-cigarettes as well as those who are exposed to e-cigarettes.”

Parker Waichman LLP continues to offer free lawsuit consultations to victims of e-cigarette injuries. If you or a loved one experienced complications or injuries following use of or exposure to e-cigarette vapors or other ingredients, please visit the firm’s e-cigarette page. Free case evaluations are also available by calling 1-800-LAW-INFO.

Related Electronic Vapor Cigarette Reviews Press Releases